Navigation Links
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
Date:1/24/2008

Amoxicillin PULSYS to be Marketed as MOXATAG(TM) - First Once-Daily

Amoxicillin Product Approved in U.S.

GERMANTOWN, Md., Jan. 24 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that it has received approval of its New Drug Application (NDA) from the U.S. Food and Drug Administration (FDA), for its once-daily MOXATAG(TM) Tablets 775 mg (amoxicillin extended-release tablets) for the treatment of adults and pediatric patients 12 years and older with pharyngitis and/or tonsillitis secondary to Streptococcus pyogenes (commonly referred to as strep throat).

The FDA approval was based on results from a Phase 3 clinical study conducted with more than 600 patients that found once-daily MOXATAG for 10 days was effective in eradicating bacteria responsible for strep throat and demonstrated statistical non-inferiority to a four times daily dose of penicillin for 10 days. MOXATAG was very well tolerated in the clinical trial.

"We are extremely gratified to have received FDA approval of our MOXATAG NDA," stated Edward Rudnic, Ph.D., president and CEO of MiddleBrook. "As the first and only once-daily amoxicillin therapy approved for marketing in the United States, we believe MOXATAG represents a major advance for patients and doctors seeking safe, effective, and convenient treatment options for strep throat. We now look forward to continuing our ongoing strategic evaluation process from a position of greater strength with this approval in hand."

In accordance with the requirements of the Pediatric Research Equity Act, MiddleBrook has agreed with the FDA to further
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
2. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
3. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
4. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
5. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
6. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
7. Surgeons Find That Laparoscopic Banding Procedure Helps Overweight Adolescents Lose Weight and Improve Health
8. New Data Show Unacceptably Low Adult Immunization Rates and That Adults Unaware of Infectious Disease Threat
9. Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
10. Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept)
11. Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 2015 Medela has announced the addition ... ® Motion™-Endure personal pumps to its Negative Pressure ... These new devices, along with the Invia ® ... provide innovative, high-quality NPWT solutions, designed to provide ... "We are happy to be able ...
(Date:3/31/2015)... --  Halyard Health (NYSE: HYH ), formerly ... new purchasing agreement with HealthTrust for its ... Halyard,s standard and ASTM-rated face masks , including ... to HealthTrust members made up of 1,350 acute care ... practices and alternate care facilities. "We ...
(Date:3/31/2015)... Columbia , March 31, 2015  InMed ... clinical stage biopharmaceutical company that specializes in developing ... appointment of Paul C. Anderson , Ph.D., ... a pharma industry veteran who brings significant drug ... Dr. Anderson is a synthetic organic chemist by ...
Breaking Medicine Technology:Medela Launches Product Line to Support Individualized Care For Negative Pressure Wound Therapy Patients 2Halyard Health Signs First GPO Contracts As Independent Company 2Halyard Health Signs First GPO Contracts As Independent Company 3InMed Pharmaceuticals Strengthens Scientific Advisory Board 2InMed Pharmaceuticals Strengthens Scientific Advisory Board 3InMed Pharmaceuticals Strengthens Scientific Advisory Board 4
... Reportlinker.com announces that a new market research ... Orphan Drugs in Asia: Guidelines and Regulatory ... Asian Market 2011 http://www.reportlinker.com/p0486821/Orphan-Drugs-in-Asia-Guidelines-and-Regulatory-Requirements-to-Help-Orphan-Drug-Products-Enter-the-Asian-Market-2011.html ... Following the example of the US FDA,s Orphan ...
... N.J. and WEST CHESTER, Pa., April 27, 2011 ... world,s most comprehensive and broadly-based manufacturer of health care ... of orthopaedic devices, today announced that they have entered ... acquire Synthes for CHF159 per share, or $21.3 billion. ...
Cached Medicine Technology:Reportlinker Adds Orphan Drugs in Asia: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market 2011 2Reportlinker Adds Orphan Drugs in Asia: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market 2011 3Reportlinker Adds Orphan Drugs in Asia: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market 2011 4Johnson & Johnson and Synthes Announce Definitive Merger Agreement to Create World's Most Innovative and Comprehensive Orthopaedics Business 2Johnson & Johnson and Synthes Announce Definitive Merger Agreement to Create World's Most Innovative and Comprehensive Orthopaedics Business 3Johnson & Johnson and Synthes Announce Definitive Merger Agreement to Create World's Most Innovative and Comprehensive Orthopaedics Business 4Johnson & Johnson and Synthes Announce Definitive Merger Agreement to Create World's Most Innovative and Comprehensive Orthopaedics Business 5Johnson & Johnson and Synthes Announce Definitive Merger Agreement to Create World's Most Innovative and Comprehensive Orthopaedics Business 6Johnson & Johnson and Synthes Announce Definitive Merger Agreement to Create World's Most Innovative and Comprehensive Orthopaedics Business 7
(Date:3/31/2015)... As the demand for optimized mobile content continues ... mobile-friendly website online sometime during the month of May ... commitment to bring the best and most accurate information ... same great fitness information at http://www.chunkfitness.com will ... read while browsing on a mobile device. , About ...
(Date:3/31/2015)... Angeles, CA (PRWEB) March 31, 2015 Dr. Parsa ... the pioneering hair transplant surgeons on the forefront of using ... A procedure once thought of, as a novelty has now become ... it comes to their hairlines. “I really do believe that beard ... a hair transplant if their donor area isn’t as dense as ...
(Date:3/31/2015)... FL (PRWEB) March 31, 2015 ... Systems (ADS) is offering advice for buying from ... Equipment Dealers Association (NMEDA) is a nonprofit organization ... professionalism in the manufacturing and installation of mobility ... companies in the industry that consistently adhere to ...
(Date:3/31/2015)... Simeon Boyd, UC Davis professor of genetics and ... from the National Institute of Dental and Craniofacial Research ... more than 10 centers in the United States and ... Italy and the United Kingdom, to study craniosynostosis, the ... in infants. , The researchers are members of the ...
(Date:3/31/2015)... March 31, 2015 Indosoft, developer of the ... 1.4 support in development of their 5.x line. The industry ... has been deployed around the world for more than a ... as a telephony platform, Q-Suite can fully embrace newer Asterisk ... call center software on Asterisk for more than a decade. ...
Breaking Medicine News(10 mins):Health News:Is Beard to Scalp Hair Transplant the Future? 2Health News:Advanced Driving Systems Celebrates National Disability Month 2Health News:International team of researchers led by UC Davis receives $4 million NIH grant to study skull disorder in infants 2Health News:International team of researchers led by UC Davis receives $4 million NIH grant to study skull disorder in infants 3Health News:Indosoft Announces End of Life for Asterisk 1.4 Support in Q-Suite 5 Call Center Software 2
... Three-Quarters Say Governments, Should Look Beyond Economics and ... Nov. 19 Three-quarters of,people in ten countries ... health, social and environmental statistics in,measuring national progress. ... the most important measure. Around 1,000 respondents ...
... Trifecta: Better at Tasks, Memory, Everyday Life, SAN ... exercise,enhances memory and other cognitive abilities of older adults, ... the Gerontological,Society of America, a gathering of 3500 aging ... Zelinski of the University of Southern California Andrus,Gerontology Center ...
... Nov. 19 At its Board Meeting on ... Minnesota approved 11,grants for new research on topics ... young adults to interventions that reduce tobacco use ... African,immigrants. ClearWay Minnesota will award more than $2.8 ...
... 18, 2007 A multinational team of researchers has shown ... the growth of a cancerous tumor without actually killing it. ... immune system to eradicate cancers, a technique known as immunotherapy. ... When the cancer can,t be killed with immune attacks, it ...
... period, study finds, , , SUNDAY, Nov. 18 (HealthDay News) -- ... known as "mini-strokes." , But make no mistake -- they ... such an attack rarely seek medical help. Just one in ... (TIA) sought the proper emergency care, a recent study published ...
... stop it from spreading, expert says , , SATURDAY, Nov. 17 (HealthDay ... get hit by the flu bug this year, but some simple ... expert said. , The flu shot is the most effective method ... medical officer at Brigham and Women,s Hospital in Boston. It,s important ...
Cached Medicine News:Health News:GLOBESCAN Survey for the BEYOND GDP Conference, European Parliament, Nov. 19th and 20th 2Health News:GLOBESCAN Survey for the BEYOND GDP Conference, European Parliament, Nov. 19th and 20th 3Health News:Brain Exercises Sharpen Memory in Older Adults 2Health News:Brain Exercises Sharpen Memory in Older Adults 3Health News:ClearWay Minnesota(SM) Board Approves $2.8 Million for Research Grants 2Health News:ClearWay Minnesota(SM) Board Approves $2.8 Million for Research Grants 3Health News:Immune system can drive cancers into dormant state 2Health News:Immune system can drive cancers into dormant state 3Health News:Immune system can drive cancers into dormant state 4Health News:Mini Strokes: Major Health Threats 2Health News:Mini Strokes: Major Health Threats 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: